These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34473353)

  • 1. Contemporary Incremental Healthcare Costs for Allergic Rhinitis in the United States.
    Workman AD; Dattilo L; Rathi VK; Bhattacharyya N
    Laryngoscope; 2022 Aug; 132(8):1510-1514. PubMed ID: 34473353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental healthcare utilization and expenditures for allergic rhinitis in the United States.
    Bhattacharyya N
    Laryngoscope; 2011 Sep; 121(9):1830-3. PubMed ID: 21997726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Incremental Healthcare Costs for Chronic Rhinosinusitis in the United States.
    Bhattacharyya N
    Laryngoscope; 2021 Oct; 131(10):2169-2172. PubMed ID: 33606274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States.
    Bhattacharyya N
    Ann Otol Rhinol Laryngol; 2011 Jul; 120(7):423-7. PubMed ID: 21859049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world evidence costs of allergic rhinitis and allergy immunotherapy in the commercially insured United States population.
    Tkacz JP; Rance K; Waddell D; Aagren M; Hammerby E
    Curr Med Res Opin; 2021 Jun; 37(6):957-965. PubMed ID: 33754932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare costs of acute and chronic tonsillar conditions in the pediatric population in the United States.
    Duarte VM; McGrath CL; Shapiro NL; Bhattacharrya N
    Int J Pediatr Otorhinolaryngol; 2015 Jun; 79(6):921-925. PubMed ID: 25912631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey.
    Law AW; Reed SD; Sundy JS; Schulman KA
    J Allergy Clin Immunol; 2003 Feb; 111(2):296-300. PubMed ID: 12589348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Literacy Impact on National Healthcare Utilization and Expenditure.
    Rasu RS; Bawa WA; Suminski R; Snella K; Warady B
    Int J Health Policy Manag; 2015 Aug; 4(11):747-55. PubMed ID: 26673335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare costs for allergic rhinitis patients on allergy immunotherapy: a retrospective observational study.
    Allen-Ramey F; Mao J; Blauer-Peterson C; Rock M; Nathan R; Halpern R
    Curr Med Res Opin; 2017 Nov; 33(11):2039-2047. PubMed ID: 28737480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical practice guideline: Allergic rhinitis.
    Seidman MD; Gurgel RK; Lin SY; Schwartz SR; Baroody FM; Bonner JR; Dawson DE; Dykewicz MS; Hackell JM; Han JK; Ishman SL; Krouse HJ; Malekzadeh S; Mims JW; Omole FS; Reddy WD; Wallace DV; Walsh SA; Warren BE; Wilson MN; Nnacheta LC;
    Otolaryngol Head Neck Surg; 2015 Feb; 152(1 Suppl):S1-43. PubMed ID: 25644617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental health care utilization and expenditures for sleep disorders in the United States.
    Huyett P; Bhattacharyya N
    J Clin Sleep Med; 2021 Oct; 17(10):1981-1986. PubMed ID: 33949943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication-related expenditures by individuals with allergic rhinitis in Nigeria.
    Adebola SO; Sogebi OA; Adebola OE; Oyinloye IF; Oguntoye MS
    Otolaryngol Head Neck Surg; 2015 Jun; 152(6):1061-7. PubMed ID: 25897007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost and resource utilization comparisons of second-generation antihistamines vs. montelukast for allergic rhinitis treatment.
    Hay J; Jhaveri M; Tangirala M; Kaliner M
    Allergy Asthma Proc; 2009; 30(6):634-42. PubMed ID: 20031009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
    Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
    Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental direct expenditure of treating asthma in the United States.
    Kamble S; Bharmal M
    J Asthma; 2009 Feb; 46(1):73-80. PubMed ID: 19191142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care resource use and associated costs among patients with seasonal versus perennial allergic rhinitis.
    Lang K; Allen-Ramey F; Huang H; Rock M; Kaufman E; Dykewicz MS
    Allergy Asthma Proc; 2016 Sep; 37(5):103-11. PubMed ID: 27657517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in common rhinologic illnesses: analysis of U.S. healthcare surveys 1995-2007.
    Mattos JL; Woodard CR; Payne SC
    Int Forum Allergy Rhinol; 2011; 1(1):3-12. PubMed ID: 22287302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization Pattern and Drug Use of Traditional Chinese Medicine, Western Medicine, and Integrated Chinese-Western Medicine Treatments for Allergic Rhinitis Under the National Health Insurance Program in Taiwan.
    Huang SK; Lai CS; Chang YS; Ho YL
    J Altern Complement Med; 2016 Oct; 22(10):832-840. PubMed ID: 27348711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost and utilization impacts of oral antihistamines in the California Medi-Cal program.
    Hay JW; Leahy M
    Value Health; 2005; 8(4):506-16. PubMed ID: 16091028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.